Science & Enterprise subscription

Follow us on Twitter

  • Medical researchers and data scientists are using artificial intelligence, or A.I., to diagnose children’s intestin… https://t.co/urHvB81IUx
    about 9 hours ago
  • New post on Science and Enterprise: A.I. Harnessed to Diagnose Children’s Gut Diseases https://t.co/K5JZp5FW7t #Science #Business
    about 9 hours ago
  • University engineers and chemists are creating a more efficient material for separating carbon dioxide from emissio… https://t.co/7hT7j4A6kd
    about 13 hours ago
  • New post on Science and Enterprise: Efficient Carbon Capture Membranes Being Developed https://t.co/98mWeDX8Xu #Science #Business
    about 14 hours ago
  • Findings from a Pew Research Center survey released this week show more Americans with smartphones use their phones… https://t.co/soaDH8vMqH
    about 2 days ago

Please share Science & Enterprise

Patent Awarded for Engineered T-Cell Cancer Therapy

Human T-cell

An experimental treatment using a person’s modified T-cells from the immune system to attack solid tumor cancers received a U.S. patent. . . . → Read More: Patent Awarded for Engineered T-Cell Cancer Therapy

Radiation-Antibody Biotech Raises $105M in Venture Funds

John Valiant

A company creating cancer treatments that combine radiation therapy with the targeting of synthetic antibodies is raising $105 million in its second round of venture financing. . . . → Read More: Radiation-Antibody Biotech Raises $105M in Venture Funds

Immuno-, Chemotherapy Shown to Shrink Pancreatic Cancers

Chemotherapy vials

Early results from a clinical trial show a combination of immunotherapy and chemotherapy drugs shrunk tumors in most participants with pancreatic cancer. . . . → Read More: Immuno-, Chemotherapy Shown to Shrink Pancreatic Cancers

Genome Editing Biotech Raises $126M in IPO

NASDAQ share price display

A biotechnology company developing treatments for disease and enhanced agricultural products with genome editing is raising $126 million in its initial public offering, or IPO, of common stock. . . . → Read More: Genome Editing Biotech Raises $126M in IPO

Population Data Show Genetics-Health Links

Population genetics

The first batch of data from a large-scale genomic sequencing project in the U.K. shows strong associations between several gene variations and common health conditions. . . . → Read More: Population Data Show Genetics-Health Links

Trial Testing Targeted Solid Tumor Immunotherapy

Alligator head

A clinical trial is underway testing the safety of a cancer therapy that harnesses the immune system, but also works only in the tumor to reduce adverse side effects. . . . → Read More: Trial Testing Targeted Solid Tumor Immunotherapy

Sequencing IDs Pancreatic Cancer Targets

DNA analysis graphic

A genomic analysis of tumor samples from patients with pancreatic cancer, a cancer with a typically poor outlook, identified targets for early precision cancer detection and treatments. . . . → Read More: Sequencing IDs Pancreatic Cancer Targets

Blood Test as Good as Biopsy to Detect Cancer Targets

Detect cancer scrabble

Results of a clinical trial show a commercial blood test works at least as well as tissue biopsies for determining precise genetic mutations causing most lung cancers. . . . → Read More: Blood Test as Good as Biopsy to Detect Cancer Targets

Gene Editing Deactivates Cause of T-Cell Side Effects

Human T-cell

A biotechnology company developing engineered T-cells as treatments for cancer, used gene editing to deactivate a likely cause of serious adverse effects from its therapies. . . . → Read More: Gene Editing Deactivates Cause of T-Cell Side Effects

Organoids Designed for Faster Cancer Diagnostics

Tumor organoids

A new process grows small samples of tumor tissue in the lab to enable high-speed diagnostics for personalized cancer treatments and drug testing. . . . → Read More: Organoids Designed for Faster Cancer Diagnostics